Dimensional Fund Advisors’s Accelerate Diagnostics AXDX Stock Holding History

Dimensional Fund Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,810	Closed	-$1.08M	–	3364
2015 Q1	$1.08M	Sell	4,810 -3,009	-38%	-$629K	﹤0.01%	2970
2014 Q4	$1.5M	Sell	7,819 -94	-1%	-$20.1K	﹤0.01%	2915
2014 Q3	$1.7M	Hold	7,913	–	–	﹤0.01%	2878
2014 Q2	$2.06M	Buy	7,913 +476	+6%	+$104K	﹤0.01%	2846
2014 Q1	$1.62M	Hold	7,437	–	–	﹤0.01%	2897
2013 Q4	$907K	Hold	7,437	–	–	﹤0.01%	3049
2013 Q3	$997K	Buy	7,437 +367	+5%	+$32.8K	﹤0.01%	3043
2013 Q2	$574K	Buy	+7,070	New	+$525K	﹤0.01%	3142

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

MGM

Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return

Dimensional Fund Advisors's AXDX Position: Q2 2015 in Review

Dimensional Fund Advisors sold out of Accelerate Diagnostics (AXDX) in Q2 2015, closing a stake of 4,810 shares — an estimated $1.08M sold.

Dimensional Fund Advisors first reported a position in AXDX in Q2 2013 and held it in 8 quarters. The position peaked at $2.06M in Q2 2014. 86 funds tracked by Wall St. Rank hold AXDX as of Q2 2015.

Dimensional Fund Advisors reported no remaining Accelerate Diagnostics position as of Q2 2015 after selling out during the quarter.
Dimensional Fund Advisors sold 4,810 Accelerate Diagnostics shares in Q2 2015, an estimated $1.08M.
Dimensional Fund Advisors first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 8 quarters.
Dimensional Fund Advisors's Accelerate Diagnostics position peaked at $2.06M in Q2 2014.
86 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2015.

Based on Dimensional Fund Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.